OR WAIT null SECS
© 2021 MJH Life Sciences™ and Pharmaceutical Executive. All rights reserved.
The Fundamental Disconnect Between Pharma and Technology
Michelle Maskaly is Pharmaceutical Executive's Senior Editor. Follow her on Twitter @mmaskaly or email her at michelle.maskaly@ubm.com
Pharmaceutical Executive
Otsuka Pharmaceutical’s President and CEO of Development and Commercialization William Carson explains the initial growing pains the company went through with their technology company partner in the early development stages of the first U.S. FDA approved digital medicine system.
Otsuka Pharmaceutical’s President and CEO of Development and Commercialization William Carson explains the initial growing pains the company went through with their technology company partner in the early development stages of the first U.S. FDA approved digital medicine system, Abilify Mycite.
His interview was recorded during the May 2018 Financial Times Live ‘s US Healthcare & Life Sciences Summit in New York City.
Related Content: